| P2093 | author name string | Priyanka Agarwal | |
| | Neil A Bhowmick | |
| | Bethany Smith | |
| P2860 | cites work | The Drosha-DGCR8 complex in primary microRNA processing | Q24318603 |
| | Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP | Q24539076 |
| | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| | Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 |
| | Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism | Q24600173 |
| | Characterization of extracellular circulating microRNA | Q24603537 |
| | The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer? | Q24617121 |
| | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 |
| | The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 |
| | MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA | Q24648090 |
| | miR-34a repression of SIRT1 regulates apoptosis | Q24652720 |
| | The basics of epithelial-mesenchymal transition | Q24652992 |
| | MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 |
| | Role of EMT in Metastasis and Therapy Resistance | Q26772923 |
| | RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action | Q26773479 |
| | RAS is regulated by the let-7 microRNA family | Q27860522 |
| | Epithelial-mesenchymal transitions in development and disease | Q27860630 |
| | The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 |
| | Identification of novel genes coding for small expressed RNAs | Q27860917 |
| | MicroRNA signatures in human cancers | Q27860962 |
| | Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA | Q27861092 |
| | Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 |
| | Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 |
| | MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation | Q28281118 |
| | A microRNA component of the p53 tumour suppressor network | Q28305330 |
| | Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy | Q28547017 |
| | Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study | Q28550381 |
| | SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 |
| | Argonaute proteins: key players in RNA silencing | Q29614714 |
| | Crystal structure of Argonaute and its implications for RISC slicer activity | Q29614980 |
| | Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor | Q29615559 |
| | Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer | Q29616123 |
| | Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer | Q29616218 |
| | TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 |
| | Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT | Q59123125 |
| | Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer | Q83316012 |
| | Circulating miRNAs are correlated with tumor progression in prostate cancer | Q84232903 |
| | MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma | Q37646533 |
| | MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression | Q37687107 |
| | Pancreatic cancer: the role of pancreatic stellate cells in tumor progression | Q37829604 |
| | Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma | Q38188317 |
| | Targeting the TGFβ pathway for cancer therapy. | Q38274752 |
| | MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors | Q38330822 |
| | MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. | Q38332381 |
| | Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis | Q38772722 |
| | The translational potential of microRNAs as biofluid markers of urological tumours. | Q38800426 |
| | MicroRNAs as regulatory elements in immune system logic | Q38819277 |
| | MicroRNA-16 suppresses epithelial-mesenchymal transition‑related gene expression in human glioma | Q38954519 |
| | Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer. | Q39017152 |
| | miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion | Q39017823 |
| | T cells redirected to EphA2 for the immunotherapy of glioblastoma | Q39258646 |
| | MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 |
| | Smad3 regulates E-cadherin via miRNA-200 pathway | Q39454247 |
| | Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer | Q39550421 |
| | miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. | Q39612245 |
| | MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer | Q39626698 |
| | MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. | Q39637718 |
| | Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery | Q40390348 |
| | Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium | Q40923257 |
| | TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 |
| | Metastatic ability: adapting to a tissue site unseen | Q41548032 |
| | Role for stromal heterogeneity in prostate tumorigenesis | Q41760480 |
| | Role of miRNA let-7 and its major targets in prostate cancer. | Q41890041 |
| | Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer | Q42112822 |
| | Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. | Q42492769 |
| | MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. | Q44031786 |
| | miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. | Q44213136 |
| | Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity | Q45405811 |
| | Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production | Q46409730 |
| | Induction of heart valve lesions by small-molecule ALK5 inhibitors. | Q51423313 |
| | Architecture of a validated microRNA::target interaction. | Q52062047 |
| | Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer. | Q53098125 |
| | Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. | Q54672329 |
| | MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity. | Q36157026 |
| | TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 |
| | Comment on "MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction" | Q36409311 |
| | MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer | Q36430771 |
| | Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel | Q36460311 |
| | MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer | Q36469814 |
| | Targeted delivery of paclitaxel to EphA2-expressing cancer cells | Q36511070 |
| | The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. | Q36536455 |
| | Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation | Q36544603 |
| | miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. | Q36586444 |
| | Tumour exosome integrins determine organotropic metastasis. | Q36677568 |
| | Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling | Q36751290 |
| | Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. | Q36764656 |
| | The metastasis-promoting roles of tumor-associated immune cells | Q36972016 |
| | The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis | Q36985643 |
| | Role of TGF-β and the tumor microenvironment during mammary tumorigenesis | Q37044604 |
| | Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer | Q37046805 |
| | Dicer, Drosha, and outcomes in patients with ovarian cancer | Q37262584 |
| | Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. | Q37284266 |
| | MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 |
| | Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment | Q37373640 |
| | Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer | Q37388344 |
| | TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage | Q37544957 |
| | A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer | Q37624417 |
| | MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation | Q30418688 |
| | MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. | Q31026166 |
| | Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer | Q33572313 |
| | Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer | Q33613644 |
| | Frequent downregulation of miR-34 family in human ovarian cancers | Q33658229 |
| | miR-10b targets Tiam1: implications for Rac activation and carcinoma migration | Q33966873 |
| | A reciprocal role of prostate cancer on stromal DNA damage | Q34000472 |
| | MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer | Q34079217 |
| | Molecular biology. Glimpses of a tiny RNA world | Q34099353 |
| | Functional MicroRNA Is Transferred between Glioma Cells | Q34137987 |
| | MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas | Q34148960 |
| | Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours | Q34150301 |
| | Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth | Q34275817 |
| | The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. | Q34278940 |
| | Mechanisms of control of microRNA biogenesis. | Q34310633 |
| | microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions | Q34375528 |
| | Clinical development success rates for investigational drugs | Q34396786 |
| | miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression | Q34448719 |
| | Cell-type-specific signatures of microRNAs on target mRNA expression | Q34479693 |
| | MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation | Q34506870 |
| | Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer | Q34526484 |
| | TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest | Q34789115 |
| | New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites | Q34972173 |
| | Genetic analysis of the mammalian transforming growth factor-beta superfamily | Q35017076 |
| | Spatiotemporal dynamics of microRNA during epithelial collective cell migration | Q35032629 |
| | Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth | Q35060278 |
| | MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart | Q35083325 |
| | The biological functions of miRNAs: lessons from in vivo studies | Q35132364 |
| | Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer | Q35161368 |
| | Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis | Q35213732 |
| | Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease | Q35584190 |
| | MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction | Q35763090 |
| | Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure | Q35964249 |
| | The miR-200 family and its targets regulate type II cell differentiation in human fetal lung. | Q36049885 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | precision medicine | Q17075943 |
| | breast neoplasm | Q23929670 |
| | microRNA | Q310899 |
| | ovarian neoplasm | Q11793790 |
| | prostate neoplasm | Q56014511 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | R157-R172 | |
| P577 | publication date | 2017-03-13 | |
| | 2017-05-01 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine | |
| P478 | volume | 24 | |